Here’s some potentially good news for postmenopausal women at risk for developing breast cancer:

Drug Arimidex Cuts Risk for Breast Cancer in Older, High-Risk Women: Study

It could be welcome addition to other preventive meds such as tamoxifen, experts say

December 12, 2013

breast cancerTHURSDAY, Dec. 12, 2013 (HealthDay News) — The drug Arimidex reduces the risk of developing breast cancer by more than 50 percent among postmenopausal women at high risk for the disease, according to a new study.

The finding, scheduled for presentation Thursday at the San Antonio Breast Cancer Symposium in Texas, adds hope that Arimidex (anastrozole) might be a valuable new preventive option for some women. The research will also be published in the journal The Lancet.

“Two other antihormone therapies, tamoxifen and raloxifene, are used by some women to prevent breast cancer, but these drugs are not as effective and can have adverse side effects, which limit their use,” study lead author Jack Cuzick said in a new release from the American Association for Cancer Research.

“Hopefully, our findings will lead to an alternative prevention therapy with fewer side effects for postmenopausal women at high risk for developing breast cancer,” said Cuzick, head of the Cancer Research U.K. Centre for Cancer Prevention and director of the Wolfson Institute of Preventive Medicine at Queen Mary University of London.

About 80 percent of U.S. breast cancer patients have tumors with high levels of hormone receptors, and these tumors are fueled by the hormone estrogen. Arimidex prevents the body from making estrogen and is therefore used to treat postmenopausal women with hormone receptor-positive breast cancer…

Here’s the link to this important story which ran on US World and News Reports site last week:

Feel good and keep smiling!  Pat

Leave a Reply